CytoSorbents Corp (CTSO)
1.185
-0.04
(-3.66%)
USD |
NASDAQ |
Oct 04, 16:00
1.19
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents Shareholders Equity (Annual): 23.28M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 23.28M |
December 31, 2022 | 35.38M |
December 31, 2021 | 62.58M |
December 31, 2020 | 79.22M |
December 31, 2019 | 3.418M |
December 31, 2018 | 16.93M |
December 31, 2017 | 10.26M |
December 31, 2016 | 1.338M |
December 31, 2015 | 8.211M |
Date | Value |
---|---|
December 31, 2014 | 3.963M |
December 31, 2013 | -14.27M |
December 31, 2012 | -11.63M |
December 31, 2011 | -10.09M |
December 31, 2010 | -0.4846M |
December 31, 2009 | 1.268M |
December 31, 2008 | 2.360M |
December 31, 2007 | -0.1043M |
December 31, 2006 | 2.363M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
3.418M
Minimum
2019
79.22M
Maximum
2020
40.77M
Average
35.38M
Median
2022
Shareholders Equity (Annual) Benchmarks
Delcath Systems Inc | 15.78M |
Star Equity Holdings Inc | 65.30M |
Exact Sciences Corp | 3.145B |
Illumina Inc | 5.745B |
Progyny Inc | 553.43M |